WHI-P180

CAS No. 211555-08-7

WHI-P180( Janex 3 )

Catalog No. M13366 CAS No. 211555-08-7

WHI-P180 is a potent EGFR and Cdk2 inhibitors with IC50 of 4.0 and 1.0 uM, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 51 In Stock
5MG 85 In Stock
10MG 124 In Stock
25MG 210 In Stock
50MG 311 In Stock
100MG 461 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WHI-P180
  • Note
    Research use only, not for human use.
  • Brief Description
    WHI-P180 is a potent EGFR and Cdk2 inhibitors with IC50 of 4.0 and 1.0 uM, respectively.
  • Description
    WHI-P180 is a potent EGFR and Cdk2 inhibitors with IC50 of 4.0 and 1.0 uM, respectively.
  • In Vitro
    ——
  • In Vivo
    WHI-P180 is also an active inhibitor of IgE-mediated mast cell responses. The elimination half-life of WHI-P180 in CD-1 mice (BALB/c mice) following i.v., i.p., or p.o. administration is less than 10 min. Systemic clearance of WHI-P180 is 6742 mL/h/kg in CD-I mice and 8188 mL/h/kg in BALB/c mice. Notably, WHI-P180, when administered in two consecutive nontoxic i.p. bolus doses of 25 mg/kg, inhibits IgE/antigen-induced vascular hyperpermeability in a well-characterized murine model of passive cutaneous anaphylaxis.
  • Synonyms
    Janex 3
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    CDK2| EGFR
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    211555-08-7
  • Formula Weight
    297.31
  • Molecular Formula
    C16H15N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    OC1=CC=CC(NC2=C3C=C(OC)C(OC)=CC3=NC=N2)=C1
  • Chemical Name
    3-[(6,7-dimethoxyquinazolin-4-yl)amino]phenol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.An R, et al. Pharm Res. 2009 Feb;26(2):449-58.
molnova catalog
related products
  • SEL120-34A hydrochlo...

    SEL120-34A is an ATP-competitive, selective, orally active CDK8 inhibitor that inhibits kinase activities of CDK8/CycC and CDK19/CycC complexes with IC50 of 4.4 nM and 10.4 nM, respectively.

  • Tuberstemonine

    Tuberstemonine exhibits relatively higher intestinal permeabilities.

  • MSC-2530818

    MSC-2530818 (MSC 2530818, MSC2530818) is a potent, selective, and orally bioavailable CDK8 inhibitor with IC50 of 2.6 nM.